Immune biomarkers associated with clinical benefit from atezolizumab (MPDL3280a; anti-PD-L1) in advanced urothelial bladder cancer (UBC). Issue 2 (December 2015)

Record Type:: Journal Article
Title:: Immune biomarkers associated with clinical benefit from atezolizumab (MPDL3280a; anti-PD-L1) in advanced urothelial bladder cancer (UBC). Issue 2 (December 2015)
Main Title:: Immune biomarkers associated with clinical benefit from atezolizumab (MPDL3280a; anti-PD-L1) in advanced urothelial bladder cancer (UBC)
Authors:: Powles, Thomas
Nickles, Dorothee
Van Allen, Eliezer
Chappey, Colombe
Zou, Wei
Kowanetz, Marcin
Kadel, Edward
Denker, Mitchell
Boyd, Zachary
Vogelzang, Nicholas
Kim, Joseph
Bellmunt, Joaquim
Loriot, Yohann
Drake, Charles
O'Hear, Carol
Fasso, Marcella
Hegde, Priti
Mariathasan, Sanjeev
Abstract:
Is Part Of:: Journal for immunotherapy of cancer. Volume 3:Issue 2(2015)
Journal:: Journal for immunotherapy of cancer
Issue:: Volume 3:Issue 2(2015)
Issue Display:: Volume 3, Issue 2 (2015)
Year:: 2015
Volume:: 3
Issue:: 2
Issue Sort Value:: 2015-0003-0002-0000
Page Start:: 1
Page End:: 2
Publication Date:: 2015-12
Subjects:: Cancer -- Immunotherapy -- Periodicals
Cancer -- Immunological aspects -- Periodicals
Tumors -- Immunological aspects -- Periodicals
Immunotherapy -- Periodicals
616.99406105
Journal URLs:: http://www.immunotherapyofcancer.org ↗
https://jitc.bmj.com/ ↗
http://link.springer.com/ ↗
DOI:: 10.1186/2051-1426-3-S2-P83 ↗
Languages:: English
ISSNs:: 2051-1426
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 10242.xml